Fidelity
Home > Boards > US Listed > Biotechs > Inovio Biomedical Corp. (INO)

enough consolidating between >40 and .43....need to get

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Med.rare Member Profile
Member Level 
Followed By 23
Posts 2,446
Boards Moderated 1
Alias Born 03/28/01
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/15/2014 2:08:34 PM
Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma "PR Newswire (US)" - 4/8/2014 1:01:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/7/2014 4:56:33 PM
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality "PR Newswire (US)" - 4/1/2014 4:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/27/2014 4:59:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/27/2014 4:58:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/27/2014 4:57:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/27/2014 4:56:47 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 3/27/2014 4:49:52 PM
Inovio Pharmaceuticals Recognized with "Best Therapeutic Vaccine" Award at World Vaccine Congress 2014 "PR Newswire (US)" - 3/26/2014 4:00:00 AM
Equities Updates, Most Active -- Research on Inovio Pharma, Oi S.A., GameStop, and Banco Bradesco "PR Newswire (US)" - 3/19/2014 8:00:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/17/2014 3:13:55 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/17/2014 11:40:04 AM
Inovio Pharmaceuticals Reports 2013 Fourth Quarter and Year End Financial Results "PR Newswire (US)" - 3/17/2014 4:00:00 AM
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2013 Financial Results on March 17, 2014 "PR Newswire (US)" - 3/12/2014 4:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/4/2014 2:06:44 PM
Inovio Pharmaceuticals Closes $63.3 Million Underwritten Financing "PR Newswire (US)" - 3/4/2014 9:49:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/27/2014 3:46:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/27/2014 3:35:59 PM
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock "PR Newswire (US)" - 2/27/2014 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/26/2014 4:14:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/26/2014 4:08:48 PM
Inovio Pharmaceuticals Announces Public Offering of Common Stock "PR Newswire (US)" - 2/26/2014 4:01:00 PM
Inovio's Revolutionary DNA Immunotherapy Product Slated for Trials in 2014, by BrokerBank Securities, Inc. "PR Newswire (US)" - 2/26/2014 7:00:00 AM
Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference "PR Newswire (US)" - 2/19/2014 4:00:00 AM
Med.rare Member Level  Friday, 01/20/12 10:18:57 AM
Re: None
Post # of 11523 
enough consolidating between >40 and .43....need to get over the 50 dma at .46 and hold it,.lots of gains between there and the 200 dma at .66

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist